It works by targeting the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, promoting reduced appetite, improved glycemic management, and weight loss
TSH (thyroid-stimulating hormone) TSH is produced by your pituitary gland
Data on tirzepatide in fatty liver disease Within a substudy with 296 participants of the SURPASS-3 trial (SURPASS-3 MRI), changes in liver fat and other fat compartments were monitored during the study, and a subgroup of the tirzepatide cohort was compared to the insulin degludec comparator subgroup (54, 79)
Before prescribing tirzepatide, ensure patients understand: The difference between expected side effects (nausea, GI symptoms) and allergic reactions Warning signs requiring immediate medical attention The importance of having emergency contact information readily available Proper injection technique according to the device Instructions for Use Ongoing monitoring should include assessment for hypersensitivity symptoms at follow-up visits, particularly during dose escalation
The jump from 5 mg to 7.5 mg frequently causes more nausea than earlier increases
